BOUT vs. JDVI ETF Comparison
Comparison of Innovator IBD Breakout Opportunities ETF (BOUT) to John Hancock Disciplined Value International Select ETF (JDVI)
BOUT
Innovator IBD Breakout Opportunities ETF
BOUT Description
The investment seeks to track, before fees and expenses, the performance of the IBD® Breakout Stocks Index (the "index"). The fund will normally invest at least 80% of its net assets (including investment borrowings) in the equity securities that comprise the index. The index seeks to provide opportunistic investment exposure to those stocks with the potential to "break out," or experience a period of sustained price growth beyond the stock's recent "resistance level," with consideration for various market conditions. The fund is non-diversified. BOUT uses technical analysis to find stocks that are likely to breakout. The funds index relies on an algorithm that establishes a base price (a recent high) for each eligible security. The index then follows the trend for each stock. Selected stocks are ranked by a combination of relative strength and fundamental factors, and then weighted in fixed tiers according to this ranking. In addition, BOUT will move 50% of its portfolio into T-bills based on market signals: a rapid increase in either margin debt or overall stock prices, combined with slowing reversing momentum in the S&P 500. The T-bill position will remain in place until the S&P 500 falls by 50% or show indications of rising momentum. BOUT is rebalanced and reconstituted weekly after the close on Friday. The frequent rebalance schedule means the fund will be highly responsive to the technical factors that drive its strategy, but could also experience high turnover.
Grade (RS Rating)
Last Trade
$40.14
Average Daily Volume
2,990
44
JDVI
John Hancock Disciplined Value International Select ETF
JDVI Description
Under normal market conditions, the fund invests at least 80% of its net assets (plus any borrowings for investment purposes) in a portfolio of equity and equity-related securities issued by non-U.S. large and mid-capitalization companies that meet the fund"s value criteria. The fund generally invests in the equity securities of issuers the manager believes are undervalued. The fund is non-diversified.Grade (RS Rating)
Last Trade
$26.42
Average Daily Volume
430
6
Performance
Period | BOUT | JDVI |
---|---|---|
30 Days | 7.95% | -4.59% |
60 Days | 9.94% | -7.28% |
90 Days | 9.81% | -6.07% |
12 Months | 32.83% |
0 Overlapping Holdings
Symbol | Grade | Weight in BOUT | Weight in JDVI | Overlap |
---|
BOUT Overweight 44 Positions Relative to JDVI
Symbol | Grade | Weight | |
---|---|---|---|
PACS | F | 4.48% | |
MS | A | 4.47% | |
LBRDK | C | 4.44% | |
NEM | D | 4.42% | |
VIK | B | 4.39% | |
EXPE | B | 4.28% | |
EQIX | A | 4.25% | |
AHR | A | 4.24% | |
IDCC | B | 4.01% | |
ETN | A | 3.82% | |
SPGI | C | 3.81% | |
EQH | C | 3.78% | |
CRM | B | 3.73% | |
BAH | F | 3.73% | |
DVA | C | 3.71% | |
PGR | A | 3.63% | |
CRDO | B | 2.87% | |
VRNS | D | 2.61% | |
ULS | B | 2.59% | |
IR | B | 2.49% | |
DT | D | 2.49% | |
NMIH | C | 2.44% | |
ONON | A | 2.35% | |
COLL | F | 2.23% | |
TSM | B | 1.31% | |
TBBK | B | 1.28% | |
NOW | A | 1.27% | |
CDNA | D | 1.24% | |
SCCO | F | 1.22% | |
SN | D | 1.2% | |
TCOM | B | 1.14% | |
BEKE | D | 1.06% | |
ROAD | B | 0.45% | |
AXON | A | 0.43% | |
TPH | D | 0.42% | |
IBKR | A | 0.42% | |
CWAN | B | 0.42% | |
AVGO | D | 0.42% | |
ALKT | B | 0.42% | |
GMED | A | 0.41% | |
CORT | B | 0.41% | |
ACGL | C | 0.4% | |
PLMR | A | 0.39% | |
JD | D | 0.38% |
BOUT: Top Represented Industries & Keywords
JDVI: Top Represented Industries & Keywords